1
|
Ali MA, Shaker OG, Khalefa AA, Abdelwahed MY, Ali E, Ezzat EM, Elghobary HA, Awaji AA, Fouad NA, Ayoub SE. Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous. Br J Biomed Sci 2020; 77:208-212. [PMID: 32614682 DOI: 10.1080/09674845.2020.1765459] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Background: Systemic Lupus Erythematous (SLE) is a chronic systemic autoimmune disorder whose diagnosis depends on combination of multiple factors. Circulating lncRNAs could serve as diagnostic non-invasive biomarkers for SLE. We hypothesised that serum FAS-AS1 and PVT1 are new biomarkers for SLE that relate to clinical features and laboratory markers. Materials and Method: Measurement of serum FAS-AS1 & PVT1 by qRT-PCR, analysis of the association between two RNAs and the clinical data, activity index and laboratory markers by standard routine methods. Results: There was a significant relative increased serum FAS-AS1 (median (IQR) 2.19 (0.13-8.62) and a significant reduced PVT1 (median (IQR) 0.52 (0.01-7.55) in SLE patients compared to controls (P < 0.0001 for FAS-AS1 and = 0.007 for PVT1). Serum FAS-AS1 and PVT1 were positively correlated (r= 0.37, P = 0.001). Higher FAS-AS1 was significantly linked with nephritis (P = 0.011), positive anti-dsDNA (P= 0.01) and lower serum PVT1 was significantly associated with oral ulcers (P= 0.023), photosensitivity (P= 0.017), and neurological manifestations (P= 0.041). Serum PVT1 negatively correlated with age (r= -0.52, P< 0.0001) and ESR level (r= -0.29, P= 0.011) in SLE patients. No correlation between disease activity and serum FAS-AS1 or PVT1 was detected. Conclusions: Our study provides evidence that serum FAS-AS1 and PVT1 are new biomarkers for SLE.
Collapse
Affiliation(s)
- M A Ali
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University Fayoum, Egypt
| | - O G Shaker
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University , Cairo, Egypt
| | - A A Khalefa
- Department of Physiology, Faculty of Medicine, Zagazig University , Zagazig, Egypt
| | - M Y Abdelwahed
- Department of Physiology, Faculty of Medicine, Fayoum University , Fayoum, Egypt
| | - Egi Ali
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Fayoum University , Fayoum, Egypt
| | - E M Ezzat
- Department of Internal Medicine, Faculty of Medicine, Fayoum University , Fayoum, Egypt
| | - H A Elghobary
- Department of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University , Cairo, Egypt
| | - A A Awaji
- University of Tabuk, University College of Taymaa, Faculty of Science, Biology Department , Tabuk, Saudi Arabia
| | - N A Fouad
- Faculty of Medicine, Department of Rheumatology and Rehabilitation, Fayoum University , Fayoum 63514, Egypt
| | - S E Ayoub
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Fayoum University Fayoum, Egypt
| |
Collapse
|